Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
11.41
-0.18 (-1.55%)
Nov 20, 2024, 4:00 PM EST - Market closed
Bioventus Market Cap
Bioventus has a market cap or net worth of $745.85 million as of November 21, 2024. Its market cap has increased by 230.40% in one year.
Market Cap
745.85M
Enterprise Value
1.15B
1-Year Change
230.40%
Ranking
Category
Stock Price
$11.41
Market Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has increased from $713.47M to $745.85M, an increase of 4.54%. That is a compound annual growth rate of 1.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 757.61M | 128.31% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
| Feb 11, 2021 | 713.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Embecta | 777.82M |
| Cronos Group | 774.25M |
| Pacira BioSciences | 772.48M |
| Avanos Medical | 768.27M |
| Cullinan Therapeutics | 762.78M |
| Prothena Corporation | 756.01M |
| Replimune Group | 749.17M |
| CARGO Therapeutics | 741.51M |